The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
Open accessAbstract
The Vaccine Safety Datalink (VSD) is a collaborative project between the Centers for Disease Control and Prevention(CDC) and 9 health care organizations. Established in 1990, VSD is a vital resource informing policy makers and the public about the safety of vaccines used in the United States. Large linked databases are used to identify and evaluate adverse events in over 9 million individuals annually. VSD generates rapid, important safety assessments for both routine vaccinations and emergency vaccination campaigns. VSD monitors safety of seasonal influenza vaccines in near-real time, and provided essential information on the safety of influenza A (H1N1) 2009 monovalent vaccine during the recent pandemic. VSD investigators have published important studies demonstrating that childhood vaccines are not associated with autism or other developmental disabilities. VSD prioritizes evaluation of new vaccines; searches for possible unusual health events after vaccination; monitors vaccine safety in pregnant women; and has pioneered development of biostatistical research methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of anaphylaxis after vaccination of children and adolescents.
Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team (2003) · PEDIATRICS · doi:10.1542/peds.112.4.815 · Cited by 320
Self-citationRisk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
France, E. K., Glanz, J., Xu, S., Hambidge, S., Yamasaki, K., Black, S. B., Marcy, M., Mullooly, J. P., Jackson, L. A., Nordin, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1578 · Cited by 165
Davis, R. L. (2001) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.155.3.354 · Cited by 123
Childhood vaccinations and risk of asthma
DESTEFANO, F., GU, D., KRAMARZ, P., TRUMAN, B. I., IADEMARCO, M. F., MULLOOLY, J. P., JACKSON, L. A., DAVIS, R. L., BLACK, S. B., SHINEFIELD, H. R., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00004 · Cited by 109
Ray, P., Hayward, J., Michelson, D., Lewis, E., Schwalbe, J., Black, S., Shinefield, H., Marcy, M., Huff, K., Ward, J., et al. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000234067.84848.e1 · Cited by 91
Cited by
A global federated real-world data and analytics platform for research
Palchuk, M. B., London, J. W., Perez-Rey, D., Drebert, Z. J., Winer-Jones, J. P., Thompson, C. N., Esposito, J., & Claerhout, B. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad035 · Cited by 948
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
“VSD can be used to assess hypotheses that arise from reviews of medical literature, reports to VAERS, changes in immunization schedules, or the introduction of new vaccines (14).”
BackgroundRisk of anaphylaxis after vaccination in children and adults.
McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., Hambidge, S. J., Lee, G. M., Jackson, L. A., Irving, S. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.048 · Cited by 381
Self-citationMbaeyi, S. A., Bozio, C. H., Duffy, J., Rubin, L. G., Hariri, S., Stephens, D. S., & MacNeil, J. R. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6909a1 · Cited by 321
Edwards, K. M., Hackell, J. M., THE COMMITTEE ON INFECTIOUS DISEASES, T. C. O. P. A. A. M., Byington, C. L., Maldonado, Y. A., Barnett, E. D., Davies, H. D., Edwards, K. M., Lynfield, R., Munoz, F. M., et al. (2016) · Pediatrics · doi:10.1542/peds.2016-2146 · Cited by 302
Metadata
- Authors
- McNeil, M. M., Gee, J., Weintraub, E. S., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R., Naleway, A. L., Jackson, L. A., Omer, S. B., Jacobsen, S. J., & DeStefano, F.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 32
- Issue
- 42
- Pages
- 5390-5398
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2010608085
- Cited by
- 247
- References
- 5
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. https://app.cochat.ai/papers/10.1016/j.vaccine.2014.07.073
- The paper
- McNeil, M. M., Gee, J., Weintraub, E. S., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R., Naleway, A. L., Jackson, L. A., Omer, S. B., Jacobsen, S. J., & DeStefano, F. (2014). The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. https://doi.org/10.1016/j.vaccine.2014.07.073
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.